Europace

(ISSN: 1099-5129, 1532-2092)

Articles Available on Medscape

 
 

Table of Contents

From Europace

2019 -

  • Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients. 
  • Innovative implantation of a leadless pacemaker in a 19 kg paediatric patient via the right internal jugular vein. 
  • Intra-atrial re-entrant tachycardia around atretic tricuspid annulus. 
  • A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes. 
  • Harnessing big data for identifying atrial fibrillation. 
  • Corrigendum to: Goldenberg I, et al. Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction. 
  • Machine learning in 'big data': handle with care. 
  • Deep sedation for transvenous lead extraction: a large single-centre experience. 
  • Agreement between gadolinium-enhanced cardiac magnetic resonance and electro-anatomical maps in patients with non-ischaemic dilated cardiomyopathy and ventricular arrhythmias. 
  • A visually striking calcific band causing monomorphic ventricular tachycardia as a first presentation of constrictive pericarditis. 
  • 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. 
  • Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. 
  • Safety and usefulness of a second Micra transcatheter pacemaker implantation after battery depletion. 
  • High resolution map of aortic root tachycardia. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. 
  • Optimum lesion set and predictors of outcome in persistent atrial fibrillation ablation: a meta-regression analysis. 
  • Atrial fibrillation screening with photo-plethysmography through a smartphone camera. 
  • Non-paroxysmal atrial fibrillation mapping: characterization of the electrophysiological substrate using a novel integrated mapping technique. 
  • Evaluation of a simple technique aiming at optimizing point-by-point isolation of the left pulmonary veins: a randomized study. 
  • Electrocardiographic optimization techniques in resynchronization therapy. 
  • Left subclavian approach for ablation of persistent left superior vena cava in a patient with cardiac resynchronization therapy: a case report. 
  • Molecular and genetic insights into progressive cardiac conduction disease. 
  • A novel atrial fibrillation prediction model for Chinese subjects: a nationwide cohort investigation of 682 237 study participants with random forest model. 
  • Erratum to: Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis [Europace 2019; doi:10.1093/europace/euy310]. 
  • Long-term results of atrial maze surgery in patients with congenital heart disease. 
  • Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study. 
  • Percutaneous transhepatic route for cardiac resynchronization therapy in a patient with superior vena cava occlusion. 
  • Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2. 
  • End-of-service management of leadless cardiac pacemakers: a case report. 
  • Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. 
  • Mortality and morbidity reduction after frequent premature ventricular complexes ablation in patients with left ventricular systolic dysfunction. 
  • Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators: commentary. 
  • Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead? 
  • Consider temporal aggressive rhythm control before ICD implantation in patients with heart failure with reduced ejection fraction. 
  • Bidirectional ventricular tachycardia in ACTH-producing pheochromocytoma. 
  • Improving first shock success in patients with atrial fibrillation undergoing electrical cardioversion. 
  • Improving first shock success in patients with atrial fibrillation undergoing electrical cardioversion: Authors' reply. 
  • Prophylactic implantable cardioverter-defibrillator in the very elderly. 
  • Pulmonary vein-gap re-entrant atrial tachycardia following atrial fibrillation ablation: an electrophysiological insight with high-resolution mapping. 
  • PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study-Authors' reply. 
  • Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation. 
  • Letter to the editor-pREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. 
  • Inadvertent transseptal puncture into the aortic root: the narrow edge between luck and catastrophe in interventional cardiology. 
  • EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. 
  • Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). 
  • Brugada electrocardiogram pattern and right bundle branch block: Authors' reply. 
  • Epicardial ablation for ventricular tachycardia in Freidreich's ataxia cardiomyopathy. 
  • Brugada electrocardiogram pattern and right bundle branch block. 
  • Adjacent multiple accessory pathways demonstrated on ultra-high-resolution mapping. 
  • Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis. 
  • Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. 
  • Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial. 
  • Left pulmonary cusp ablation of refractory ventricular arrhythmia originating from the inaccessible summit. 
  • QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial. 
  • Sex differences in rate and rhythm control for atrial fibrillation. 
  • Predictors of atrial ectopy and their relationship to atrial fibrillation risk. 
  • Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure. 
  • Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators. 
  • Ventricular conduction stability test: a method to identify and quantify changes in whole heart activation patterns during physiological stress. 
  • Therapy of ventricular arrhythmias in patients suffering from isolated left ventricular non-compaction cardiomyopathy. 
  • Decline in incidence of sudden cardiac death in the young: a 10-year nationwide study of 8756 deaths in Denmark. 
  • The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial. 
  • Clinical implications of redefining recurrence of atrial fibrillation following catheter ablation. 
  • Clinical implications of redefining recurrence of atrial fibrillation following catheter ablation: Authors' reply. 
  • Career building in countries with electrophysiology underdevelopment: roadblocks and solutions-an EHRA Young EP Report. 
  • Comment on "Venous access site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multi-centre experience on efficacy and complications". 
  • Differential presentation of atrioventricular nodal re-entrant tachycardia in athletes and non-athletes. 
  • Thoracoscopic maze: yes, we can, but should we? 
  • Mechanistic insights from targeted molecular profiling of repolarization alternans in the intact human heart. 
  • Early experience of thoracoscopic vs. catheter ablation for atrial fibrillation. 
  • Omnipolarity applied to equi-spaced electrode array for ventricular tachycardia substrate mapping. 
  • Undersensing, asynchronous pacing, and ventricular fibrillation. 
  • Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications. 
  • The importance of identifying conduction breakthrough sites across the mitral isthmus by elaborate mapping for mitral isthmus linear ablation. 
  • Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial. 
  • Clinical impact of speckle tracking echocardiography for detecting the origin of posterior papillary muscle ventricular arrhythmia. 
  • Lead extraction for reduction of chronic pain related to cardiovascular implantable electronic device. 
  • Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation. 
  • Thoracoscopic ablation for the treatment of atrial fibrillation: a systematic outcome analysis of a multicentre cohort. 
  • Protamine reversal of heparin: a fishy practice? 
  • Termination of ventricular tachycardia with high-power ablation after endocardial entrainment of a non-endocardial circuit in a patient with left ventricular assist device. 
  • Catheter-driven His bundle pacemaker lead implantation. 
  • Lead extraction in patients with cardiac resynchronization therapy devices: are they worse than the others? 
  • ELECTRa-from myth to aletheia: risk factors for transvenous lead extraction in the ancillary analysis of the European Lead Extraction ConTRolled (ELECTRa) study. 
  • Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits. 
  • Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction. 
  • Cardiac arrest following protamine administration: a case series. 
  • Reproducibility and accuracy of late gadolinium enhancement cardiac magnetic resonance measurements for the detection of left atrial fibrosis in patients undergoing atrial fibrillation ablation procedures. 
  • Risk factors for atrioventricular block after transcatheter aortic valve implantation: a single-centre analysis including assessment of aortic calcifications and follow-up. 
  • Successful slow pathway ablation in a patient with an interrupted inferior vena cava and persistent left superior vena cava. 
  • His-bundle pacing: promise for the future. 
  • Radiofrequency ablation of right ventricular tachycardia in patients with no femoral access: safety and efficacy of a superior approach. 
 
 
kokun.net